Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocugen (OCGN) Invested Capital: 2014-2025

Historic Invested Capital for Ocugen (OCGN) over the last 11 years, with Sep 2025 value amounting to $30.3 million.

  • Ocugen's Invested Capital fell 30.44% to $30.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.3 million, marking a year-over-year decrease of 30.44%. This contributed to the annual value of $55.4 million for FY2024, which is 27.73% up from last year.
  • Per Ocugen's latest filing, its Invested Capital stood at $30.3 million for Q3 2025, which was up 2.81% from $29.4 million recorded in Q2 2025.
  • In the past 5 years, Ocugen's Invested Capital registered a high of $127.2 million during Q1 2022, and its lowest value of $19.8 million during Q2 2024.
  • Its 3-year average for Invested Capital is $43.5 million, with a median of $43.4 million in 2023.
  • Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 519.04% in 2021, then slumped by 68.08% in 2024.
  • Ocugen's Invested Capital (Quarterly) stood at $97.5 million in 2021, then dropped by 21.80% to $76.3 million in 2022, then plummeted by 43.14% to $43.4 million in 2023, then rose by 27.73% to $55.4 million in 2024, then plummeted by 30.44% to $30.3 million in 2025.
  • Its last three reported values are $30.3 million in Q3 2025, $29.4 million for Q2 2025, and $42.0 million during Q1 2025.